Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Scots debut whey-omega-3 blend

By Shane Starling , 03-Dec-2009
Last updated on 04-Dec-2009 at 11:25 GMT2009-12-04T11:25:10Z

Scottish omega-3 supplier, Equateq, has added to its range by blending a high-dose EPA omega-3 form with whey in a debut targeting the sports market.

The company said it had chosen to employ EPA (eicosapentaenoic acid) rather than DHA (docosahexaenoic acid) or any other fatty acid, because of the anti-inflammation benefits that EPA has demonstrated.

The company, which was born three years ago and produces pharma-grade, high-dose omega-3 oils from its Scottish base, said the whey-omega-3 blend was capable of delivering 135mg of its sardine-derived EPA powder.

Chief executive officer, Adam Kelliher, told that the new offering would sell for, “just shy of €30 per kilogram” depending on volumes.

“There is a strong interest in whey among the sports community,” he said this morning. “We’ve begun discussions with sports companies that have been very encouraging.”

Equateq employs its Crystalpure technology to produce high-dose oils that can reach as high as 99 per cent. For this reason its major markets are in the pharma area and the firm is scaling up its operations to meet growing demand in this area.

For the current application, it has produced an enriched triglyceride oil that is 50 per cent omega-3. This enables the lipid fraction in the blend to be reduced to 30 percent which presents formulation advantages as oxidation rates are reduced.

The company is targeting breakfast shakes, as a sprinkle on food, and a cooking ingredient at low heats.

At 135mg per dose, the company said recommended dosages of 500mg could be achieved with three teaspoons of the formulation.

Crystalpure enables saturates and mono-unsaturates to be transformed into crystals, which facilitates, “the physical separation of the polyunsaturated stream.”

Equateq splits its business between pharma and nutraceutical clients, noting its concentrations for pharma were all about being “super pure”, whereas nutra was much more about offering customised blends.

Frost & Sullivan notes 24 per cent annual growth in the omega-3 sector, projecting a global market worth $1.6bn by 2014.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars